Not only are IR mRNA levels decreased with type 2 diabetes compared to those controls without a history of type 2 diabetes, but the insulin-stimulated IR signaling response is also blunted in those individuals with type 2 diabetes [46]. The gene discussed is INS; the disease is type 2 diabetes mellitus.